Atorvastatin 3-Isopropyl Ether tert-Butyl Ester
✓
100% accuracy
of data
24/7 scientific
support
⬡
0% tolerance in
quality of product

Stock Locations

  • New Jersey, USA
  • Czech Republic, EU
  • Mumbai, India

* Stock subject to availability.

1797009-04-1Atorvastatin 3-Isopropyl Ether tert-Butyl Ester

● In Stock

Catalogue No.:VE0026707
CAS No.:1797009-04-1
Mol. Formula:C40H49FN2O5
Mol. Weight:656.8 g/mol

Additional information on CAS 1797009-04-1

Parent drug

Atorvastatin

IUPAC Name

Tert-butyl (3R,5R)-7-[2-(4-fluorophenyl)-3-phenyl-4-(phenylcarbamoyl)-5-propan-2-ylpyrrol-1-yl]-5-hydroxy-3-propan-2-yloxyheptanoate

Pharmacopeial Synonyms

N/A

Synonyms

N/A

Smiles

O=C(C1=C(C(C)C)N(CC[C@H](C[C@H](CC(OC(C)(C)C)=O)OC(C)C)O)C(C2=CC=C(F)C=C2)=C1C3=CC=CC=C3)NC4=CC=CC=C4

InChI

InChI=1S/C40H49FN2O5/c1-26(2)37-36(39(46)42-31-16-12-9-13-17-31)35(28-14-10-8-11-15-28)38(29-18-20-30(41)21-19-29)43(37)23-22-32(44)24-33(47-27(3)4)25-34(45)48-40(5,6)7/h8-21,26-27,32-33,44H,22-25H2,1-7H3,(H,42,46)/t32-,33-/m1/s1

Description

Atorvastatin 3-Isopropyl Ether tert-Butyl Ester impurity (CAS 1797009-04-1) is a synthesis-related degradant observed during atorvastatin manufacture, typically formed through incomplete esterification or solvent-mediated alkyl exchange and capable of affecting assay, purity and stability metrics. Analytical identification relies on HPLC with UV detection, LC-MS for accurate mass confirmation and 1H and 13C NMR for structural assignment. Effective control measures include optimized reaction stoichiometry, targeted purification by column chromatography or recrystallization and validated cleaning protocols to prevent cross-contamination. Routine monitoring against ICH Q3A aligned acceptance criteria ensures impurity levels remain within specification and product quality is preserved.

Request a Quote

« * » indique les champs nécessaires

Ce champ n’est utilisé qu’à des fins de validation et devrait rester inchangé.
Products quotation
Name
Url